Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy.

Ibbotson SH.

Front Med (Lausanne). 2018 Jul 2;5:184. doi: 10.3389/fmed.2018.00184. eCollection 2018.

2.

Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.

Collier NJ, Haylett AK, Wong TH, Morton CA, Ibbotson SH, McKenna KE, Mallipeddi R, Moseley H, Seukeran D, Ward KA, Mohd Mustapa MF, Exton LS, Green AC, Rhodes LE.

Br J Dermatol. 2018 Jun 11. doi: 10.1111/bjd.16838. [Epub ahead of print] Review.

PMID:
29889302
3.

Field-change actinic keratosis and immunosuppression: therapeutic options.

Ibbotson SH.

Br J Dermatol. 2018 Apr;178(4):829-830. doi: 10.1111/bjd.16409. No abstract available.

PMID:
29668097
4.

A review of photodiagnostic investigations over 26 years: experience of the National Scottish Photobiology Service (1989-2015).

Nassan H, Dawe RS, Moseley H, Ibbotson SH.

J R Coll Physicians Edinb. 2017 Dec;47(4):345-350. doi: 10.4997/JRCPE.2017.408.

PMID:
29537405
5.

Menthol reduces phototoxicity pain in a mouse model of photodynamic therapy.

Wright L, Baptista-Hon D, Bull F, Dalgaty F, Gallacher M, Ibbotson SH, Hales TG.

Pain. 2018 Feb;159(2):284-297. doi: 10.1097/j.pain.0000000000001096.

PMID:
29194091
6.

Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.

Fargnoli MC, Ibbotson SH, Hunger RE, Rostain G, Gaastra MTW, Eibenschutz L, Cantisani C, Venema AW, Medina S, Kerrouche N, PĂ©rez-Garcia B.

J Eur Acad Dermatol Venereol. 2018 May;32(5):757-762. doi: 10.1111/jdv.14691. Epub 2017 Dec 26.

7.

Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythema dose.

Eadie E, Ibbotson SH, Dawe RS.

Br J Dermatol. 2018 Jan;178(1):297-298. doi: 10.1111/bjd.16005. Epub 2017 Nov 29. No abstract available.

PMID:
28940196
8.

Polymorphic light eruption with severe abnormal phototesting sensitivity (PLESAPS).

Harkins CP, Waters AJ, Dawe RS, Ferguson J, Ibbotson SH.

Photodermatol Photoimmunol Photomed. 2017 Nov;33(6):326-328. doi: 10.1111/phpp.12322. Epub 2017 Jun 22. No abstract available.

PMID:
28580732
9.

Phototherapy and photochemotherapy for polymorphic light eruption desensitization: a five-year case series review from a university teaching hospital.

Aslam A, Fullerton L, Ibbotson SH.

Photodermatol Photoimmunol Photomed. 2017 Jul;33(4):225-227. doi: 10.1111/phpp.12310. Epub 2017 May 11. No abstract available.

PMID:
28419574
10.

Shedding light on drug photosensitivity reactions.

Ibbotson SH.

Br J Dermatol. 2017 Apr;176(4):850-851. doi: 10.1111/bjd.15449. No abstract available.

PMID:
28418140
11.

Ultraviolet A1 phototherapy: One center's experience.

Attili SK, Dawe RS, Ibbotson SH.

Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):60-65. doi: 10.4103/0378-6323.182805.

12.

Filaggrin genotype does not determine the skin's threshold to UV-induced erythema.

Forbes D, Johnston L, Gardner J, MacCallum SF, Campbell LE, Dinkova-Kostova AT, McLean WHI, Ibbotson SH, Dawe RS, Brown SJ.

J Allergy Clin Immunol. 2016 Apr;137(4):1280-1282.e3. doi: 10.1016/j.jaci.2015.11.022. Epub 2016 Jan 29. No abstract available.

13.

Can antioxidant-rich blackcurrant juice drink consumption improve photoprotection against ultraviolet radiation?

Ray S, Belch JJ, Craigie AM, Khan F, Kennedy G, Hill A, Barton KL, Dawe RS, Ibbotson SH.

Br J Dermatol. 2016 May;174(5):1101-3. doi: 10.1111/bjd.14299. Epub 2016 Jan 24. No abstract available.

PMID:
26581666
14.

Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.

Kulyk O, Ibbotson SH, Moseley H, Valentine RM, Samuel ID.

Photodiagnosis Photodyn Ther. 2015 Dec;12(4):630-9. doi: 10.1016/j.pdpdt.2015.10.002. Epub 2015 Oct 20.

PMID:
26467274
15.

Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans.

Knatko EV, Ibbotson SH, Zhang Y, Higgins M, Fahey JW, Talalay P, Dawe RS, Ferguson J, Huang JT, Clarke R, Zheng S, Saito A, Kalra S, Benedict AL, Honda T, Proby CM, Dinkova-Kostova AT.

Cancer Prev Res (Phila). 2015 Jun;8(6):475-86. doi: 10.1158/1940-6207.CAPR-14-0362. Epub 2015 Mar 24.

16.

Practice when minimal phototoxic and minimal erythema doses are not determinable.

Macfarlane L, Bhoyrul B, Ibbotson SH, Dawe RS.

Photodermatol Photoimmunol Photomed. 2015 Jul;31(4):224-6. doi: 10.1111/phpp.12172. Epub 2015 Apr 1. No abstract available.

PMID:
25771856
17.

Loss-of-Function Mutations in the Gene Encoding Filaggrin Are Not Strongly Associated with Chronic Actinic Dermatitis.

Harkins CP, Waters A, Kerr A, Campbell L, Irwin McLean WH, Brown SJ, Ibbotson SH.

J Invest Dermatol. 2015 Jul;135(7):1919-1921. doi: 10.1038/jid.2015.64. Epub 2015 Mar 3. No abstract available.

18.

The effect of 222-nm UVC phototesting on healthy volunteer skin: a pilot study.

Woods JA, Evans A, Forbes PD, Coates PJ, Gardner J, Valentine RM, Ibbotson SH, Ferguson J, Fricker C, Moseley H.

Photodermatol Photoimmunol Photomed. 2015 May;31(3):159-66. doi: 10.1111/phpp.12156. Epub 2015 Jan 15.

PMID:
25495690
19.

Drug-induced photosensitivity.

Dawe RS, Ibbotson SH.

Dermatol Clin. 2014 Jul;32(3):363-8, ix. doi: 10.1016/j.det.2014.03.014. Review.

PMID:
24891058
20.

Review of an established UK home phototherapy service 1998-2011: improving access to a cost-effective treatment for chronic skin disease.

Cameron H, Yule S, Dawe RS, Ibbotson SH, Moseley H, Ferguson J.

Public Health. 2014 Apr;128(4):317-24. doi: 10.1016/j.puhe.2014.01.011. Epub 2014 Apr 13. Review.

PMID:
24726005
21.

Topical photodynamic therapy for non-malignant skin conditions: experience from a university teaching hospital.

Lau YN, Moseley H, Ibbotson SH.

Photodermatol Photoimmunol Photomed. 2014 Oct;30(5):280-2. doi: 10.1111/phpp.12116. Epub 2014 Mar 3. No abstract available.

PMID:
24517855
22.

Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.

Deeni YY, Ibbotson SH, Woods JA, Wolf CR, Smith G.

PLoS One. 2013 Sep 23;8(9):e75494. doi: 10.1371/journal.pone.0075494. eCollection 2013.

23.

The acute inflammatory response to photodynamic therapy.

Ibbotson SH.

Br J Dermatol. 2013 Sep;169(3):491-2. doi: 10.1111/bjd.12495. No abstract available.

PMID:
24033154
24.

A survey of photodynamic therapy services in dermatology departments across Scotland.

Ibbotson SH, Dawe RS, Morton CA.

Clin Exp Dermatol. 2013 Jul;38(5):511-6. doi: 10.1111/ced.12051. Epub 2013 Apr 30.

PMID:
23627462
25.

Modelling fluorescence in clinical photodynamic therapy.

Valentine RM, Ibbotson SH, Wood K, Brown CT, Moseley H.

Photochem Photobiol Sci. 2013 Jan;12(1):203-13. doi: 10.1039/c2pp25271f.

PMID:
23128146
26.

Monte Carlo simulations for optimal light delivery in photodynamic therapy of non-melanoma skin cancer.

Valentine RM, Wood K, Brown CT, Ibbotson SH, Moseley H.

Phys Med Biol. 2012 Oct 21;57(20):6327-45. doi: 10.1088/0031-9155/57/20/6327. Epub 2012 Sep 19.

PMID:
22990348
27.

Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?

Ibbotson SH, Valentine R, Hearn R.

Photodermatol Photoimmunol Photomed. 2012 Oct;28(5):272-3. doi: 10.1111/j.1600-0781.2012.00684.x.

PMID:
22971196
28.

Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study.

Ibbotson SH, Ferguson J.

Photodermatol Photoimmunol Photomed. 2012 Oct;28(5):235-9. doi: 10.1111/j.1600-0781.2012.00681.x.

PMID:
22971187
29.

Photodynamic therapy and immunosuppression.

Ibbotson SH.

Br J Dermatol. 2012 Sep;167(3):465-7. doi: 10.1111/j.1365-2133.2012.11189.x. No abstract available.

PMID:
22924947
30.

Prevalence and predictors of low vitamin D status in patients referred to a tertiary photodiagnostic service: a retrospective study.

Reid SM, Robinson M, Kerr AC, Ibbotson SH.

Photodermatol Photoimmunol Photomed. 2012 Apr;28(2):91-6. doi: 10.1111/j.1600-0781.2011.00644.x.

PMID:
22409712
31.

Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature.

Attili SK, Ibbotson SH, Fleming C.

Photodermatol Photoimmunol Photomed. 2012 Apr;28(2):68-79. doi: 10.1111/j.1600-0781.2011.00640.x. Review.

PMID:
22409709
32.

Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report.

Kerr AC, Ferguson J, Attili SK, Beattie PE, Coleman AJ, Dawe RS, Eberlein B, Goulden V, Ibbotson SH, Menage Hdu P, Moseley H, Novakovic L, Walker SL, Woods JA, Young AR, Sarkany RP.

Clin Exp Dermatol. 2012 Apr;37(3):219-26. doi: 10.1111/j.1365-2230.2011.04256.x. Epub 2012 Jan 25. Review.

PMID:
22277060
33.

A case of false-negative monochromator phototesting in a patient with chronic actinic dermatitis taking prednisolone.

Ferguson J, Ibbotson SH.

Br J Dermatol. 2012 Jul;167(1):214-5. doi: 10.1111/j.1365-2133.2012.10834.x. No abstract available.

PMID:
22250731
34.

Characterization of a human keratinocyte HaCaT cell line model to study the regulation of CYP2S1.

McNeilly AD, Woods JA, Ibbotson SH, Wolf CR, Smith G.

Drug Metab Dispos. 2012 Feb;40(2):283-9. doi: 10.1124/dmd.111.042085. Epub 2011 Oct 28.

35.

Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.

Ibbotson SH, Dawe RS, Dinkova-Kostova AT, Weidlich S, Farr PM, Ferguson J, Wolf CR, Smith G.

Br J Dermatol. 2012 Feb;166(2):380-8. doi: 10.1111/j.1365-2133.2011.10661.x. Epub 2012 Jan 9.

PMID:
21967523
36.

Localized bullous pemphigoid induced by photodynamic therapy.

Rakvit P, Kerr AC, Ibbotson SH.

Photodermatol Photoimmunol Photomed. 2011 Oct;27(5):251-3. doi: 10.1111/j.1600-0781.2011.00609.x.

PMID:
21950630
37.

Irradiance is an important determinant of pain experienced during topical photodynamic therapy.

Ibbotson SH.

J Am Acad Dermatol. 2011 Jul;65(1):201-2. doi: 10.1016/j.jaad.2010.11.060. No abstract available.

PMID:
21679812
38.

Parameters associated with severe pain during photodynamic therapy: results of a large Scottish series.

Waters AJ, Ibbotson SH.

Br J Dermatol. 2011 Sep;165(3):696-8. doi: 10.1111/j.1365-2133.2011.10429.x. Epub 2011 Aug 4. No abstract available.

PMID:
21623746
39.

Adverse effects of topical photodynamic therapy.

Ibbotson SH.

Photodermatol Photoimmunol Photomed. 2011 Jun;27(3):116-30. doi: 10.1111/j.1600-0781.2010.00560.x. Review.

PMID:
21535165
40.

Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria.

Sarkany RP, Ibbotson SH, Whatley SD, Lawrence CM, Gover P, Mufti GJ, Murphy GM, Masters GS, Badminton MN, Elder GH.

J Invest Dermatol. 2011 May;131(5):1172-5. doi: 10.1038/jid.2011.5. Epub 2011 Feb 17. No abstract available.

41.

A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.

Valentine RM, Ibbotson SH, Brown CT, Wood K, Moseley H.

Photochem Photobiol. 2011 Jan-Feb;87(1):242-9. doi: 10.1111/j.1751-1097.2010.00829.x. Epub 2010 Nov 15.

PMID:
21077899
42.

Randomized double-blind comparative study of 8-methoxypsoralen bath plus UV-A treatment regimens.

Berroeta L, Man I, Dawe RS, Ferguson J, Ibbotson SH.

Actas Dermosifiliogr. 2010 Oct;101(8):729-30. No abstract available.

PMID:
20965019
43.

A randomized comparison of methods of selecting narrowband UV-B starting dose to treat chronic psoriasis.

Dawe RS, Cameron HM, Yule S, Ibbotson SH, Moseley HH, Ferguson J.

Arch Dermatol. 2011 Feb;147(2):168-74. doi: 10.1001/archdermatol.2010.286. Epub 2010 Oct 18.

PMID:
20956635
44.

Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrow band (TL-01) UVB phototherapy.

Smith G, Weidlich S, Dawe RS, Ibbotson SH.

Pharmacogenet Genomics. 2011 Apr;21(4):217-24. doi: 10.1097/FPC.0b013e32833efb36.

PMID:
20802377
45.

An overview of topical photodynamic therapy in dermatology.

Ibbotson SH.

Photodiagnosis Photodyn Ther. 2010 Mar;7(1):16-23. doi: 10.1016/j.pdpdt.2009.12.001. Epub 2009 Dec 29. Review.

PMID:
20230989
46.

Photodynamic therapy and cancer.

Brown SB, Ibbotson SH.

BMJ. 2009 Jul 1;339:b2459. doi: 10.1136/bmj.b2459. No abstract available.

PMID:
19570834
47.

How we treat Bowen's disease with topical photodynamic therapy in Dundee.

Attili SK, Ibbotson SH.

Photodiagnosis Photodyn Ther. 2009 Mar;6(1):41-5. doi: 10.1016/j.pdpdt.2009.04.001. Epub 2009 May 5.

PMID:
19447370
48.

Time course for development of psoralen plus ultraviolet A erythema following oral administration of 5-methoxypsoralen.

Berroeta L, Attili S, Wong A, Man I, Dawe RS, Ferguson J, Ibbotson SH.

Br J Dermatol. 2009 Mar;160(3):717-9. doi: 10.1111/j.1365-2133.2008.09007.x. Epub 2009 Jan 13. No abstract available.

PMID:
19183168
49.

Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial.

Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, Calzavara-Pinton P, Varma S, Roelandts R, Wolf P.

Eur J Dermatol. 2008 Sep-Oct;18(5):547-53. doi: 10.1684/ejd.2008.0472. Epub 2008 Aug 8.

PMID:
18693158
50.

Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.

Ezughah FI, Affleck AG, Evans A, Ibbotson SH, Fleming CJ.

J Dermatolog Treat. 2008;19(3):156-8. doi: 10.1080/09546630701759603.

PMID:
18569271

Supplemental Content

Loading ...
Support Center